Guner, Osman SerhatTumay, Latif Volkan2023-02-212023-02-212021-01-0110.1016/j.asjsur.2021.01.011https://hdl.handle.net/11443/1988http://dx.doi.org/10.1016/j.asjsur.2021.01.011Background: In rectal cancer, extramural vascular invasion (EMVI) is the presence of tumour cells in blood vessels outside the muscular layer, which is associated with poor prognosis. Regression of EMVI on MRI following neoadjuvant chemoradiotherapy or its persistence may have prognostic implications. Methods: This retrospective study included 52 patients with rectal cancer who underwent total mesorectal excision following long-course neoadjuvant chemoradiotherapy (CRT). EMVI assessments were done on previous pelvic MRIs obtained before neoadjuvant CRT and eight weeks after the completion of neoadjuvant chemoradiotherapy in initially EMVI positive cases. Results: Persistently EMVI positive patients had worse overall survival and disease-free survival compared to initially EMVI negative patients and patients who returned to negative (p < 0.001 for both). Multivariate analysis identified persistent EMVI positivity after neoadjuvant treatment (HR, 102.9p = 0.003) as significant independent predictor of worse overall survivaland persistent EMVI positivity (HR, 17.0p = 0.002), mesorectal fascia involvement after neoadjuvant treatment (HR, 8.0p = 0.017), and poor differentiation (HR, 10.3, p = 0.012) as significant independent predictors of worse disease-free survival. Conclusion: Persistent EMVI positivity after neoadjuvant therapy appears to be an independent factor for poor overall survivaland persistent EMVI positivity as well as mesorectal fascia involvement on post neoadjuvant therapy MRI and poor differentiation appears to be important predictors of poor disease free survival in rectal cancer patients. (c) 2021 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).Extramural vascular invasion (EMVI)Magnetic resonance imaging (MRI)Neoadjuvant chemoradiotherapyOutcomeRectal cancerSurvivalArticleWOS:000657395000005